CVS Health's Double Edged Transformation CVS Health Corporation's latest earnings call revealed a mix of encouraging growth and pressing challenges that underscore the complexities of the healthcare industry's ongoing evolution.
The company's deliberate focus on margin recovery and operational discipline has yielded impressive results, with Aetna's performance showcasing over $2 billion in year over year improvement in adjusted operating income.
The 340B program remains a contentious issue, with pharmaceutical manufacturers imposing restrictions that impact purchasing economics.